{"id":"https://openalex.org/W2053551315","doi":"https://doi.org/10.1158/1538-7445.am2012-1758","title":"Abstract 1758: A podophyllotoxin derivative, Adva-27a, is more potent at killing multi-drug resistant breast cancer cells than etoposide","display_name":"Abstract 1758: A podophyllotoxin derivative, Adva-27a, is more potent at killing multi-drug resistant breast cancer cells than etoposide","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2053551315","doi":"https://doi.org/10.1158/1538-7445.am2012-1758","mag":"2053551315"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-1758","doi":"https://doi.org/10.1158/1538-7445.am2012-1758","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1758","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032702979","display_name":"Rebecca S. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123946342","display_name":"Binghamton University","ror":"https://ror.org/008rmbt77","country_code":"US","type":"education","lineage":["https://openalex.org/I123946342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca S. Young","raw_affiliation_strings":["1Binghamton Univ., Binghamton, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Binghamton Univ., Binghamton, NY","institution_ids":["https://openalex.org/I123946342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052395691","display_name":"Si Yan Liao","orcid":"https://orcid.org/0000-0002-3532-3999","observed_orcids":["https://orcid.org/0000-0002-3532-3999"]},"institutions":[{"id":"https://openalex.org/I123946342","display_name":"Binghamton University","ror":"https://ror.org/008rmbt77","country_code":"US","type":"education","lineage":["https://openalex.org/I123946342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Si Liao","raw_affiliation_strings":["1Binghamton Univ., Binghamton, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Binghamton Univ., Binghamton, NY","institution_ids":["https://openalex.org/I123946342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027072098","display_name":"Steve N. Slilaty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve N. Slilaty","raw_affiliation_strings":["2Sunshine Biopharma Inc., Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sunshine Biopharma Inc., Montreal, Quebec, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024756657","display_name":"Susannah Gal","orcid":"https://orcid.org/0000-0001-5422-7807","observed_orcids":["https://orcid.org/0000-0001-5422-7807"]},"institutions":[{"id":"https://openalex.org/I123946342","display_name":"Binghamton University","ror":"https://ror.org/008rmbt77","country_code":"US","type":"education","lineage":["https://openalex.org/I123946342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susannah Gal","raw_affiliation_strings":["1Binghamton Univ., Binghamton, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Binghamton Univ., Binghamton, NY","institution_ids":["https://openalex.org/I123946342"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"1758","last_page":"1758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12360","display_name":"Plant-derived Lignans Synthesis and Bioactivity","score":0.6772000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12360","display_name":"Plant-derived Lignans Synthesis and Bioactivity","score":0.6772000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.16169999539852142,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.09200000017881393,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/podophyllotoxin-derivatives","display_name":"podophyllotoxin derivatives","score":0.9399999976158142},{"id":"https://openalex.org/keywords/c-glycosides","display_name":"C-glycosides","score":0.8109999895095825},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.6869999766349792},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8930000066757202},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.5379999876022339},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.5630000233650208},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.8474525213241577},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.6825580596923828},{"id":"https://openalex.org/C2778143360","wikidata":"https://www.wikidata.org/wiki/Q421193","display_name":"Podophyllotoxin","level":2,"score":0.535946249961853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49513569474220276},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46349120140075684},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.46193018555641174},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.41370242834091187},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.38042891025543213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3405648469924927},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31173986196517944},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24196189641952515},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17958644032478333},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.17697852849960327},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.13438913226127625},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-1758","doi":"https://doi.org/10.1158/1538-7445.am2012-1758","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1758","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108182487","https://openalex.org/W1482690359","https://openalex.org/W2073073775","https://openalex.org/W2390250148","https://openalex.org/W7112593695","https://openalex.org/W2058737180","https://openalex.org/W2978464165","https://openalex.org/W2382055066","https://openalex.org/W1965022269","https://openalex.org/W6962256691"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"novel":[2],"non-ester":[3],"GEM-difluorinated":[4],"C-glycoside":[5],"derivative":[6],"of":[7,19,45,56,98,132,156,170,180,182,190,192,216,232,247,256,278,307,312],"podophyllotoxin,":[8],"Adva-27a,":[9,107,119],"had":[10],"been":[11],"designed":[12],"and":[13,38,68,92,104,221],"synthesized.":[14],"The":[15,85,126],"growth":[16],"inhibitory":[17],"properties":[18],"this":[20,46,147,245],"drug":[21,150,171,268],"compared":[22],"to":[23,90,175,253,286],"the":[24,54,57,109,112,133,142,162,167,177,183,188,193,197,217,222,229,233,248,263,271,274,279,297,308,313],"currently":[25],"used":[26],"Topoisomerase":[27],"II":[28],"inhibitor":[29],"etoposide":[30,103,287],"was":[31,116],"evaluated":[32],"in":[33,39,53,95,152,228,276,296],"MCF-7":[34,86,114,135,143,164,220,224,281],"breast":[35],"cancer":[36],"cells":[37,50,87,115,136,200,225,237,257,282],"a":[40,73,259,266],"multi-drug":[41],"resistant":[42],"(MDR)":[43],"variant":[44],"cell":[47,234],"line.":[48],"These":[49],"were":[51,88,226],"cultured":[52],"presence":[55],"drugs":[58],"at":[59,158,258],"different":[60,139],"concentrations":[61],"(0.1-100\u03bcM)":[62],"for":[63,70,102,106,111,124,128,141,161,273,283,316],"various":[64],"times":[65],"(1-9":[66],"days)":[67],"analyzed":[69,196],"viability":[71,157],"using":[72,204],"mitochondrial":[74],"metabolic":[75],"activity":[76],"dye,":[77],"Alamar":[78],"blue":[79],"versus":[80],"solvent":[81],"(DMSO)":[82],"treated":[83,199],"cells.":[84,145,185],"sensitive":[89],"Adva-27a":[91,131,198,264,284],"etoposide,":[93],"resulting":[94],"an":[96],"IC50":[97,110],"less":[99,153],"than":[100,122,140,154],"10\u03bcM":[101],"20\u03bcM":[105],"while":[108,166],"MDR":[113,134,163,223,280],"25\u03bcM":[117],"with":[118,214],"but":[120,292],"greater":[121],"100\u03bcM":[123,149],"etoposide.":[125],"timing":[127],"killing":[129,181],"by":[130,201,244],"appeared":[137],"significantly":[138],"parent":[144,184],"In":[146],"case,":[148],"resulted":[151],"50%":[155],"day":[159],"3":[160],"cells,":[165],"same":[168,178],"concentration":[169,246],"required":[172],"5-6":[173],"days":[174,243],"cause":[176,254],"level":[179],"To":[186],"determine":[187],"mechanism":[189,272],"action":[191],"drug,":[194,218],"we":[195],"flow":[202],"cytometry":[203],"propidium":[205],"iodide":[206],"staining.":[207],"We":[208],"found":[209],"that":[210],"after":[211,241],"24":[212],"hours":[213],"30\u03bcM":[215],"both":[219],"accumulating":[227],"G2/M":[230],"phase":[231],"cycle.":[235],"Both":[236],"are":[238],"similarly":[239],"killed":[240],"7":[242],"drug.":[249],"Etoposide":[250],"is":[251,288],"known":[252],"accumulation":[255],"similar":[260,267],"phase,":[261],"implying":[262],"has":[265],"target.":[269],"Thus,":[270],"difference":[275],"sensitivity":[277],"relative":[285],"not":[289],"yet":[290],"understood,":[291],"will":[293],"be":[294],"explored":[295],"future.":[298],"Citation":[299],"Format:":[300],"{Authors}.":[301],"{Abstract":[302],"title}":[303],"[abstract].":[304],"In:":[305],"Proceedings":[306],"103rd":[309],"Annual":[310],"Meeting":[311],"American":[314],"Association":[315],"Cancer":[317,328],"Research;":[318],"2012":[319],"Mar":[320],"31-Apr":[321],"4;":[322],"Chicago,":[323],"IL.":[324],"Philadelphia":[325],"(PA):":[326],"AACR;":[327],"Res":[329],"2012;72(8":[330],"Suppl):Abstract":[331],"nr":[332],"1758.":[333],"doi:1538-7445.AM2012-1758":[334]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}